BioNeutra Global Corporation announced earnings results for the second quarter ended June 30, 2020. For the second quarter, the company announced sales was CAD 6.338 million compared to CAD 9.022 million a year ago. Net income was CAD 168,540 compared to net loss of CAD 4.660 million a year ago. Basic eps was CAD 0 compared to basic loss per share of CAD 0.1 a year ago. For the half year, sales was CAD 13.504 million compared to CAD 17.653 million a year ago. Net loss was CAD 956,328 compared to CAD 5.791 million a year ago. Basic loss per share was CAD 0.02 compared to CAD 0.13 a year ago.